Cipla Partner Pharmathen Receives 9 USFDA Observations
Cipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
Health
Vitamin D and Animal-Source Vitamin A May Help Reduce Uterine Fibroid Size, reveals research
A new study published in the journal of BMC Women’s Health showed that uterine fibroids (UF) may shrink if vitamin D supplements and animal-based forms of vitamin A are consumed.…
Mepolizumab Effective and Safe in Severe Eosinophilic Asthma: Meta-Analysis
China: Researchers have found in a new meta-analysis that mepolizumab is an effective and safe treatment for severe eosinophilic asthma, leading to improved lung function, fewer exacerbations, and better asthma…
Pemphigus not significantly associated with Psychiatric Disorders: Study
A new study published in the journal of JID Innovations revealed that pemphigus is not significantly associated with an increased risk of most psychiatric disorders when compared to matched controls,…
STAT+: China expected to soon surpass U.S. in bio innovation
And other biotech news, brought to you by The Readout newsletter
STAT+: Pharmalittle: We’re reading about an Eli Lilly deal, an Amgen acquisition, and much more
Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more than $1 billion
Health Bulletin 07/January/2026
Here are the top health stories for the day: NTA Issues Document Advisory for NEET UG 2026 AspirantsThe National Testing Agency (NTA) has issued an important advisory for aspirants appearing…
Patient seeks legal action after guide wire left inside chest at Thiruvananthapuram Hospital
Thiruvananthapuram: Following alleged medical negligence during a thyroid gland removal surgery at Thiruvananthapuram General Hospital, a 26-year-old woman has decided to approach the court, seeking legal action against the Health…
JB Chemicals to Infuse Up to Rs 18 Crore into Dubai Arm Unique Pharma Labs
"The additional investment in equity shares of UPL FZE would be utilized towards operational requirements of UPL FZE," the company said.
Biocon Biologics Eyes USD 75 Billion Oncology Market, Adds 3 New Biosimilar Drugs
These products are among the largest oncology biologics expected to lose exclusivity over the next five years.